Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bregni

Showing results (21-30 of 102) with videos related to

Pageof 11
Sort By:
Haematologica|January 1, 1990
Heterogeneity of circulating hematopoietic progenitors in cancer patients treated with high-dose cyclophosphamide and recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF)S Siena, M Bregni, F Ravagnani, et al.
Haematologica|July 1, 1991
Flow cytometry to estimate circulating hematopoietic progenitors for autologous transplantation: comparative analysis of different CD34 monoclonal antibodiesS Siena, M Bregni, B Brando, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1991
Prolonged disease-free survival after high-dose sequential chemo-radiotherapy and haemopoietic autologous transplantation in poor prognosis Hodgkin's diseaseA M Gianni, S Siena, M Bregni, et al.
Journal of Biological Regulators and Homeostatic Agents|April 1, 1989
Immunotoxin mediated killing of clonable T-lymphocytes infiltrating an irreversibly rejected human renal allograftS Siena, M Bregni, A Formosa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1990
Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphomaA M Gianni, M Bregni, S Siena, et al.
Experimental Hematology|November 1, 1993
Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factorsS Siena, M Bregni, L Bonsi, et al.
Lancet (London, England)|September 9, 1989
Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantationA M Gianni, S Siena, M Bregni, et al.
Transplantation|November 1, 1988
Evaluation of antihuman T lymphocyte saporin immunotoxins potentially useful in human transplantationS Siena, M Bregni, A Formosa, et al.
Blood|May 15, 1992
Recombinant human interleukin-3 and recombinant human granulocyte-macrophage colony-stimulating factor administered in vivo after high-dose cyclophosphamide cancer chemotherapy: effect on hematopoiesis and microenvironment in human bone marrowA Orazi, G Cattoretti, R SchirĂ³, et al.
Haematologica|January 1, 1989
Detection of occult leukemic cells in the autologous bone marrow graft of a patient with T-cell acute lymphoblastic leukemia by a highly specific and sensitive assayM Bregni, S Siena, M Subar, et al.
Pageof 11

Showing results (21-30 of 102) with videos related to

Sort By:
Pageof 11
Haematologica|January 1, 1990
Heterogeneity of circulating hematopoietic progenitors in cancer patients treated with high-dose cyclophosphamide and recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF)S Siena, M Bregni, F Ravagnani, et al.
Haematologica|July 1, 1991
Flow cytometry to estimate circulating hematopoietic progenitors for autologous transplantation: comparative analysis of different CD34 monoclonal antibodiesS Siena, M Bregni, B Brando, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1991
Prolonged disease-free survival after high-dose sequential chemo-radiotherapy and haemopoietic autologous transplantation in poor prognosis Hodgkin's diseaseA M Gianni, S Siena, M Bregni, et al.
Journal of Biological Regulators and Homeostatic Agents|April 1, 1989
Immunotoxin mediated killing of clonable T-lymphocytes infiltrating an irreversibly rejected human renal allograftS Siena, M Bregni, A Formosa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1990
Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphomaA M Gianni, M Bregni, S Siena, et al.
Experimental Hematology|November 1, 1993
Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factorsS Siena, M Bregni, L Bonsi, et al.
Lancet (London, England)|September 9, 1989
Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantationA M Gianni, S Siena, M Bregni, et al.
Transplantation|November 1, 1988
Evaluation of antihuman T lymphocyte saporin immunotoxins potentially useful in human transplantationS Siena, M Bregni, A Formosa, et al.
Blood|May 15, 1992
Recombinant human interleukin-3 and recombinant human granulocyte-macrophage colony-stimulating factor administered in vivo after high-dose cyclophosphamide cancer chemotherapy: effect on hematopoiesis and microenvironment in human bone marrowA Orazi, G Cattoretti, R SchirĂ³, et al.
Haematologica|January 1, 1989
Detection of occult leukemic cells in the autologous bone marrow graft of a patient with T-cell acute lymphoblastic leukemia by a highly specific and sensitive assayM Bregni, S Siena, M Subar, et al.
Pageof 11